Webinar — Strategic Considerations for a Successful CNS Clinical Development Pathway

Описание: Altasciences’ virtual session hosted by Dr. Beatrice Setnik, Chief Scientific Officer, on the strategic considerations for a successful clinical development pathway for CNS-active drugs.
What will you learn?
• How to leverage your early phase clinical trials to capture relevant data to characterize your CNS-active drug.
• The methods to determine the need for additional studies and enable developers to accurately project their clinical development timeline and have more informed discussions with regulatory agencies.

Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.

Visit our website to learn more: https://www.altasciences.com/clinical...

#Altasciences #ScientificReserach #Pharmacology #ClinicalTrials #ClinicalResearch #Biopharmaceutics #PharmaceuticalIndustry